Seòmar agus comataidhean

The Scottish Government has carefully considered Professor Ken Muir’s report Putting Learners at the Centre: Towards a Future Vision for Scottish Education which produced important recommendations for Scottish education. In response to a wide range of reports and evidence, the Education Reform Programme will deliver significant changes for the education system, including a new national agency and a Centre for Teaching Excellence.

Providing equitable support to the profession, including in relation to curriculum and assessment, is a fundamental consideration of all aspects of the Education Reform Programme. Education Scotland continues to deliver its functions while the new organisations are being developed, and continually reviews its support offering to ensure it is effective and fit for purpose.

The Scottish Government Consolidated Accounts confirms the investment in the NHS estate in each parliamentary session as:

2022-23 = £516m

2021-22 = £536m

A link to the Consolidated Accounts for each year is provided:

Scottish Government Consolidated Accounts: year ended 31 March 2022

Scottish Government Consolidated Accounts: year ended 31 March 2023

Public Health Scotland is responsible for ongoing surveillance of hepatitis C and will monitor achievement and maintenance of the elimination target in Scotland. This intelligence, combined with expert advice such as through the Scottish Health Protection Network’s Viral Hepatitis Group, will be used to inform an effective, flexible and evidence-based approach to maintaining elimination. It should also be noted that some of the key interventions for hepatitis C elimination, such as such as injecting equipment provision, will continue to be important for preventing other blood borne viruses and health outcomes.

Community optometrists across Scotland will normally refer patients who require secondary care directly to the hospital eye service in the relevant Health Board. Patients with suspected papilloedema require an emergency referral in common with some other ophthalmic conditions. Pathways for direct emergency referrals from community optometrists exist in all Health Boards in Scotland and are used regularly.

The responses to the consultation on the draft guidance on the Delivery of relationships, sexual health and parenthood (RSHP) education are currently being analysed ahead of the report being prepared for publication. The Scottish Government expects to publish a report on the consultation analysis in Spring 2024.

Mycoplasma pneumonia infection typically is not severe but it can cause a pneumonia that is usually mild in nature. PHS has reviewed routine surveillance data available to them and are reassured that most presentations of mycoplasma pneumoniae infections are of a mild respiratory illness, with children most commonly presenting at GPs with common respiratory symptoms. To date, there have been no deaths in 1280 CARI patients positive for mycoplasma pneumoniae (up to week 7) within 28 days of their test.

The Scottish Government notes that PHS continues to encourage good hand and respiratory hygiene to help stop the spread of winter bugs, including mycoplasma pneumoniae. By keeping hands clean and helping to ensure children practice good respiratory hygiene, the spread of this infection can be reduced. The Scottish Government notes that information on managing the symptoms of common winter illnesses including self-help guides and advice on preventing onward transmission, can be found on NHS Inform. ( https://www.nhsinform.scot/winter-illness/ )

PHS has advised the Scottish Government that mycoplasma pneumoniae is a common cause of respiratory infections, particularly in school-aged children. Most infections display as a mild respiratory illness, however, some persons experience severe pneumonia and require hospitalization. Significant cyclical increases in mycoplasma pneumoniae infections are observed every 3–5 years, likely because of changes in the circulating strain.

Mycoplasma pneumoniae is one of many respiratory conditions to re-emerge following cessation of nonpharmaceutical interventions, including lockdowns and physical distancing, implemented as part of the pandemic response. After implementation of nonpharmaceutical interventions in response to COVID-19, the frequency of identified mycoplasma pneumoniae infections in Scotland substantially declined beginning in 2020, as was the case for other respiratory infections. Beginning in the autumn of 2023, the United States, China and other countries identified a re-emergence of the infection, a pattern similar to that observed in Scotland.

Since November 2021, sentinel surveillance data have been available for mycoplasma pneumoniae in Scotland through the CARI sentinel surveillance programme. In this programme, sentinel GP practices across Scotland recruit and swab patients with symptoms of acute respiratory infection. These samples are all tested for ten respiratory pathogens, including mycoplasma pneumoniae. Enhanced surveillance data, primarily relating to symptoms, are collected by an online questionnaire from patients tested in the programme. Analyses from these data suggest that most infections display as a mild respiratory illness. To date, there have been no deaths in 1280 CARI patients positive for mycoplasma pneumoniae (up to week 7) within 28 days of their test. With the information from CARI, GP providers have been advised that they should consider mycoplasma pneumoniae as part of the differential diagnosis for community-acquired pneumonia cases.

PHS separately analyses data on all microbiology laboratory specimen results across Scotland to identify positive mycoplasma pneumoniae test in hospitals or care homes, or as requested in the community (by GPs). These data are reviewed by PHS and NHS Health Boards to identify any clusters or trends resulting in severe disease that warrant further intervention. To date, no unusual outbreaks or evidence of increased severity of disease has been noted and public health guidance on management of cases/clinical treatment remains unchanged.

The Scottish Government recognises that surveillance is a critical part of our approach to monitoring and managing the spread and prevalence of mycoplasma pneumoniae, Covid-19 and other respiratory infections. Public Health Scotland (PHS) are responsible for delivering Scotland’s National Respiratory Surveillance Plan with the support of the Scottish Government.

As part of PHS’s work, respiratory infection levels, including those of mycoplasma pneumoniae, and their impact are closely monitored throughout the year using various sources of data, including microbiological sampling and laboratory test results from community and hospital settings, NHS 24 calls, primary care consultations, hospital admissions, and mortality by cause. Intelligence generated from the different Scottish surveillance systems, including for mycoplasma pneumoniae, are used to inform proactive measures to prevent spread and ensure timely clinical response.

There are currently 25 members of the Co-Production Group. Six are serving teachers, and two additional secondary teachers have been invited to join the group, which will bring the total to eight. The following stakeholders are represented:

• Teachers and practitioners
• Convention of Scottish Local Authorities (COSLA)
• Education Scotland
• Scottish Qualifications Authority (SQA)
• Scottish Council of Deans of Education (SCDE)
• General Teaching Council for Scotland (GTCS)
• Association of Directors of Education (ADES)
• Education Institute of Scotland (EIS)
• NASUWT
• School Leaders Scotland (SLS)
• AHDS
• Scottish Council of Independent Schools (SCiS)
• Scottish Secondary Teachers’ Association (SSTA)
• CLD Standards Council
• Early Years Scotland
• Scottish Social Services Council
• National Centre for Gaelic Language and Culture

The Co-Production Group is one part of the overall co-production process. Ongoing additional engagement with teachers and stakeholders will take place as part of the design process.